Hubungan Pemeriksaan Basil Tahan Asam pada Penderita Tuberkulosis Sebelum dan Sesudah Pengobatan Rifampicin Selama 6 Bulan di Rumah Sakit Tingkat III 04.06.01 Wijaya Kusuma Purwokerto
DOI:
https://doi.org/10.57214/jusika.v5i1.548Keywords:
TBC, TestCepatMolekuler(GeneXpert), ZheilNeelsenAbstract
Tuberculosis is a lung infection caused by the bacteria Mycobacterium tuberculosis. Early detection is one of the ways to detect tuberculosis. The first detection of tuberculosis is with the Molecular Rapid Test, which is one of the technologies being developed using GeneXpert. Patients with positive Molecular Rapid Test results will be treated with rifampicin for 6 months, then further screening of Acid-Fast Bacilli microscopically will be carried out to determine whether the patient is still positive for pulmonary tuberculosis or not. The purpose of this study was to determine the relationship between acid-fast bacillus examination in tuberculosis patients with positive molecular rapid test results. This study will be conducted experimentally. The results of calculations using the Wilcoxon Test showed that there was a relationship between TCM examination results and BTA follow-up screening in TB patients after and before rifampicin treatment for 6 months.
References
Dinas Kesehatan Provinsi Jawa Tengah. (2023). Workshop pendampingan pengobatan TBC anak oleh keluarga. [online] Dinas Kesehatan Provinsi Jawa Tengah. Retrieved from [URL]
Djasang, S., Kalma, K., Hikmawati, E., & Armah, Z. (2022). Tingkat positifitas Mycobacterium tuberculosis menggunakan TCM dengan hasil konversi awal pengobatan short regimen pasien TB MDR. Jurnal Media Analisis Kesehatan, 13(1), 16–27.
Kementerian Kesehatan Republik Indonesia. (2020). Program penanggulangan tuberkulosis. Jakarta: Kementerian Kesehatan Republik Indonesia.
Kementerian Kesehatan Republik Indonesia. (2022). Materi inti 1 penemuan pasien tuberkulosis. Jakarta: Kementerian Kesehatan Republik Indonesia.
Meyrisca, M., Susanti, R., & Nurmainah. (2022). Hubungan kepatuhan penggunaan obat anti tuberkulosis dengan keberhasilan pengobatan pasien tuberkulosis di Puskesmas Sungai Betung Bengkayang. Lumbung Farmasi: Jurnal Ilmu Kefarmasian, 3(2), 277–282.
Panggayuh, P. L., Winarno, M., & Tama, T. D. (2019). Faktor yang berhubungan dengan keberhasilan pengobatan tuberkulosis paru di Rumah Sakit Umum Karsa Husada Batu. Sport Science and Health, 1(1), 28–38.
Rivani, E., Sabrina, T., & Patricia, V. (2019). Perbandingan uji diagnostik GeneXpert MTB/RIF untuk mendeteksi resistensi rifampicin Mycobacterium tuberculosis pada pasien TB paru di RSUP dr. Moh. Hoesin Palembang. Jurnal Kedokteran dan Kesehatan Publikasi Ilmiah Fakultas Kedokteran Universitas Sriwijaya, 6(1), 23–28.
Sampurno, O. D. (2015). Tinjauan farmakogenomik rifampisin. Jurnal Biotek Medisiana Indonesia, 4(2), 59–70.
Wahyudi, A. (2023). Banyumas sampai akhir November 2023, ada 4.211 kasus TBC di Kabupaten Banyumas, 30 persennya anak-anak. Serayu News. Retrieved from [URL]
